Enterprise Value
477.5M
Cash
334.3M
Avg Qtr Burn
-40.47M
Short % of Float
26.47%
Insider Ownership
1.49%
Institutional Own.
-
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Phase 3 Data readout | ||
Phase 3 Data readout | ||
VRDN-001 SC Details Thyroid Eye Disease | Phase 1 Data readout | |
VRDN-003 Details Thyroid Eye Disease | Phase 1 Data readout |